Itochu Chemical Frontier Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Itochu Chemical Frontier Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10540
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Itochu Chemical Frontier Corp (ICF), formerly Ando Kaseihin KK, a subsidiary of Itochu Corporation, is a chemical company that manufactures and markets chemical products. The company’s business division includes intermediate chemical division, performance product division, eco chemical and life science division, kansai division and pharmaceutical division. It offers acrylic acid and acrylic esters, MMA and other methacrylic esters, toluene, xylene, IPA, MEK, MIBK, ethyl acetate, heptane, hexane, ammonia, SM, cyclohexanone, isposable diaper materials, cosmetics raw materials. ICF provides aluminium paste, masterbatch, PVA, raw materials for resins, paints and plastic additives, paper chemicals and organic chemical intermediates. The company has its presence in Tokyo, Osaka, Nagoya and Kawasaki. ICF is headquartered in Tokyo, Japan.

Itochu Chemical Frontier Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Gene Techno Science Enters into Agreement with Itochu Chemical Frontier 10
Gene Techno Science Enters Into Co-Development Agreement With Itochu Chemical Frontier 11
Equity Offering 12
Gene Techno Science Completes Private Placement Of Shares For US$2 Million 12
Acquisition 13
Itochu Chemical Frontier Invests in Scilex Pharma 13
Itochu Chemical Frontier Corp – Key Competitors 14
Itochu Chemical Frontier Corp – Key Employees 15
Itochu Chemical Frontier Corp – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Key Facts 2
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Itochu Chemical Frontier Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gene Techno Science Enters into Agreement with Itochu Chemical Frontier 10
Gene Techno Science Enters Into Co-Development Agreement With Itochu Chemical Frontier 11
Gene Techno Science Completes Private Placement Of Shares For US$2 Million 12
Itochu Chemical Frontier Invests in Scilex Pharma 13
Itochu Chemical Frontier Corp, Key Competitors 14
Itochu Chemical Frontier Corp, Key Employees 15
Itochu Chemical Frontier Corp, Other Locations 16

List of Figures
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Itochu Chemical Frontier Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Itochu Chemical Frontier Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mitie Group Plc (MTO):企業の財務・戦略的SWOT分析
    Mitie Group Plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Wilbur-Ellis Holdings Inc:企業の戦略的SWOT分析
    Wilbur-Ellis Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Hankook Tire & Technology Co Ltd (161390):企業の財務・戦略的SWOT分析
    Hankook Tire & Technology Co Ltd (161390) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Decmil Group Ltd (DCG):企業の財務・戦略的SWOT分析
    Summary Decmil Group Ltd (Decmil), is a provider of construction, engineering and accommodation and project management services. The company provides services such as design, accommodation services, civil engineering, construction, and maintenance services, among others. Decmil provides government i …
  • Minoryx Therapeutics sl-製薬・医療分野:企業M&A・提携分析
    Summary Minoryx Therapeutics sl (Minoryx) is a clinical stage biotechnology company that develops treatments for life threatening rare diseases. The company provides discovery, preclinical research, development and clinical trial programs. It develops ALD-MIN, morquio B and PCT drugs used for lysoso …
  • Diamondback Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Diamondback Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Diamondback Energy Inc (Diamondback Energy) is an oil and gas company that offers exploration and development programs. The company acquires, develops, explores and exploits unconventional, on …
  • Almac Discovery Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Almac Discovery Ltd (Almac Discovery) a subsidiary of Almac Group Ltd is a healthcare service provider that discovers and develops drugs for the treatment of cancer. The company develops drugs, small molecule and therapeutic peptide, biomarkers and diagnostic tools. It provides early drug di …
  • Huber+Suhner AG (HUBN):企業の財務・戦略的SWOT分析
    Huber+Suhner AG (HUBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Morgans Hotel Group Co:戦略・SWOT・企業財務分析
    Morgans Hotel Group Co - Strategy, SWOT and Corporate Finance Report Summary Morgans Hotel Group Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Al Taif Technical Services PJSC:企業の戦略・SWOT・財務分析
    Al Taif Technical Services PJSC - Strategy, SWOT and Corporate Finance Report Summary Al Taif Technical Services PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Liechtensteinische Landesbank Ag:企業の戦略・SWOT・財務分析
    Liechtensteinische Landesbank Ag - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • QAF Limited:企業の戦略・SWOT・財務情報
    QAF Limited - Strategy, SWOT and Corporate Finance Report Summary QAF Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • WAVE Life Sciences Ltd (WVE):企業の財務・戦略的SWOT分析
    Summary Wave Life Sciences Ltd (Wave Life Sciences) formerly WAVE Life Sciences Pte Ltd, discovers, develops and commercializes medicines for genetic diseases. The company's pipeline comprises an mRNA transcript candidates: WVE-120101 and WVE-120102 for Huntington's disease; ATXN3 gene candidate for …
  • Banyan Biomarkers Inc:医療機器:M&Aディール及び事業提携情報
    Summary Banyan Biomarkers Inc (Banyan Biomarkers) is a medical technology company that commercializes vitro diagnostic tests for the detection of traumatic brain injury and neurological diseases. The company’s product pipeline includes biomarkers for depression, hypoxic ischemic encephalopathy, neur …
  • Oversea-Chinese Banking Corp Ltd:企業の戦略・SWOT・財務情報
    Oversea-Chinese Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Oversea-Chinese Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Covanta Holding Corp (CVA):企業の財務・戦略的SWOT分析
    Covanta Holding Corp (CVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ultra Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Ultra Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Ultra Petroleum Corp (Ultra) is an independent upstream company, which develops, produces, operates, explores, and acquires oil and natural gas properties. It develops long-life natural gas rese …
  • DexCom Inc (DXCM):医療機器:M&Aディール及び事業提携情報
    Summary DexCom Inc (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company’s major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring syst …
  • United Engineers Limited:企業の戦略・SWOT・財務情報
    United Engineers Limited - Strategy, SWOT and Corporate Finance Report Summary United Engineers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Shanghai Kinetic Medical Co Ltd (300326):医療機器:M&Aディール及び事業提携情報
    Summary Shanghai Kinetic Medical Co Ltd (KMC) is a medical device company. The company’s product categories include orthopaedics, ENT products, and vascular surgery products. Its orthopaedic products comprise wire anchor, cervical anterior nail plate system, vertebral dilatation ballon catheter, bon …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆